Cyclolab Ltd

CycloLab Ltd. is a Budapest-based research and development company specializing in cyclodextrin technology since 1972. The company focuses on four core areas: large-scale cGMP manufacturing of excipients like Sulfobutylether beta-cyclodextrin (Dexolve™), operating as a Contract Research Organization (CRO) for pharmaceutical and industrial product development, maintaining a global web shop with a comprehensive catalog of cyclodextrin derivatives, and conducting advanced R&D into next-generation proprietary molecules and applications. Their manufacturing operations are supported by FDA-approved Drug Master Files and GMP certifications, enabling the production of high-grade materials for clinical and commercial use.

These capabilities are critical for customers in the pharmaceutical, cosmetic, food, and agrochemical industries looking to improve the solubility, stability, and bioavailability of their formulations. By providing both specialized custom synthesis and analytical services—such as method development, validation, and stability testing—CycloLab supports clients through all stages of the product lifecycle, from research and pilot-scale development to commercial-scale supply. The company is internationally recognized for its expertise and has significantly contributed to medical advancements, including supporting the development of therapies for rare diseases like Niemann-Pick type C.